Lipids & metabolic liver disease

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

The risk of developing MASLD increases as the level of cardiometabolic indices increases. Obesity may serve as a mediating factor in the aforementioned association. TyG-BMI showed the strongest association with the onset of MASLD and its progression to liver fibrosis, proved to be outperformed other cardiometabolic indicators, and could be the best clinical non-invasive biomarker for early screening of MASLD and liver fibrosis.

Study context

Population
Adults aged ≥18 years free of MASLD at baseline, Dalian Health Management Cohort (DHMC)
Participants
25,366 adults82,445 person-years
Exposure
Highest vs lowest quartile of cardiometabolic indices
Outcome
Incident MASLD
Methodological detailsCox proportional hazards regression, restricted cubic splines, mediation analysis, time-dependent ROC
  • Cox proportional hazards regression
  • Restricted cubic splines
  • Mediation analysis
  • Time-dependent ROC

Main finding

As reported in the abstract

Incident MASLD, highest vs lowest quartile
Each group vs lowest quartileEstimate (95% CI)
Highest quartile
HR (CMI) 6.11(5.45–6.86)
Highest quartile
HR (AIP) 4.58(4.11–5.10)
Highest quartile
HR (TyG) 3.55(3.21–3.92)
Highest quartile
HR (TyG-BMI) 13.55(11.80–15.57)
Highest quartile
HR (TyG-WC) 12.52(10.93–14.34)
Highest quartile
HR (TyG-WHtR) 11.37(9.96–12.98)
Developed MASLD during follow-up
5378 (21.2%)

Observational data: associations, not effects.

Further findings

Progression to liver fibrosis

HR (95% CI)
TyG-BMI1.36 (1.18–1.57)
Other cardiometabolic indices not associated with liver fibrosis

Proportion of association with MASLD mediated by BMI

Cardiometabolic index (CMI)
40.4%
Atherogenic index of plasma (AIP)
33.2%
Triglyceride glucose (TyG)
36.5%
Triglyceride glucose-body mass index (TyG-BMI)
- 10.4%
Triglyceride glucose-waist circumference (TyG-WC)
37.4%
Triglyceride glucose-waist height ratio (TyG-WHtR)
48.5%

Prediction of MASLD onset (time-dependent ROC)

TyG-BMI had superior predictive ability for MASLD onset vs other indicators

Original publication

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. Published 3 April 2025. doi:10.1186/s12933-025-02716-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.